These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 681701)

  • 21. [Treatment of cystic dysplasia of the breast by the trephine-sclerosing method].
    Sanchakova AV; Dymarskiĭ LIu
    Sov Med; 1975 Aug; (8):111-5. PubMed ID: 1233738
    [No Abstract]   [Full Text] [Related]  

  • 22. [Mastodynia and fibrocystic disease of the breast. Perspectives and methods of medical treatment].
    van Bogaert LJ
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(6):805-11. PubMed ID: 3794218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The rationale for a wider range of progestogens.
    Skouby SO
    Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Steroid hormone receptors in benign breast diseases].
    Fournier S; Prud'homme JF; Martin PM; Kuttenn F
    Pathol Biol (Paris); 1983 Nov; 31(9):767-73. PubMed ID: 6361674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hormonal function of the ovarian corpus luteum during benign mammary diseases].
    Mauvais-Jarvis P; Tamborini A; Sterkers N; Ohlgiesser G; Mowszowicz I
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):965-70. PubMed ID: 1219052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dydrogesterone and other progestins in benign breast disease: an overview.
    Schindler AE
    Arch Gynecol Obstet; 2011 Feb; 283(2):369-71. PubMed ID: 20383772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
    Mueck AO; Seeger H; Wallwiener D
    Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Counseling protocol for early cancer detection at the Women's Health Center in Ruma].
    Nedić B; Ravić J; Loncar S; Cuk D
    Med Pregl; 1999; 52(3-5):162-4. PubMed ID: 10518403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Should the menopause be treated ? When and how? (author's transl)].
    Soria R
    Sem Hop; 1980 Sep 18-25; 56(33-36):1374-9. PubMed ID: 6252629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The microenvironment of human breast with clinical cancer.
    Sarnelli R; Squartini F
    Appl Pathol; 1983; 1(6):323-32. PubMed ID: 6679791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug treatment of benign breast diseases].
    Schulz KD
    Fortschr Med; 1980 Sep; 98(36):1359-64. PubMed ID: 7461541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
    Seeger H; Wallwiener D; Mueck AO
    Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of benign breast pathology with bromocriptine].
    Tolino A; Cardone A; Mastrantonio P; Chiacchio G
    Riv Ital Ginecol; 1977; 58(5):371-8. PubMed ID: 555037
    [No Abstract]   [Full Text] [Related]  

  • 37. Relationship of mastodynia with its endocrine environment and treatment in a double blind trial with lynestrenol.
    Colin C; Gaspard U; Lambotte R
    Arch Gynakol; 1978 Feb; 225(1):7-13. PubMed ID: 345994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction.
    Isern AE; Tengrup I; Loman N; Olsson H; Ringberg A
    J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1177-87. PubMed ID: 17938010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast fine needle aspiration cytology. Utility as a screening tool for clinically palpable lesions.
    Costa MJ; Tadros T; Hilton G; Birdsong G
    Acta Cytol; 1993; 37(4):461-71. PubMed ID: 8328240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of danazol on discrete benign breast lumps.
    Gateley CA; Maddox PR; Courtney SP; Mansel RE
    J R Coll Surg Edinb; 1995 Dec; 40(6):371-3. PubMed ID: 8583437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.